Related Experiment Videos
Adverse neurologic events: risks of intracardiac versus extracardiac surgery
1Mercy Medical Center, Redding, CA 96001, USA.
Insights
Intracardiac surgery poses a higher risk of central nervous system events than coronary artery bypass grafting due to embolization. Improved assessment and monitoring may reduce neurologic risks in cardiac surgery patients.
Area of Science:
- Cardiovascular Surgery
- Neurology
- Embolic Phenomena
Background:
- Intracardiac operations, like valve replacements, have higher central nervous system (CNS) complication rates (4.2-13%) compared to coronary artery bypass grafting (CABG) (0.6-5.2%).
- Increased risk is linked to macroembolization of air or particulate matter during intracardiac procedures, particularly during aortic manipulation and bypass weaning.
- Neurologic risk in CABG is rising due to complex patient profiles, including older individuals with severe aortic atherosclerosis and cerebrovascular disease.
Purpose of the Study:
- To analyze the risk of central nervous system (CNS) outcomes in patients undergoing intracardiac operations versus coronary artery bypass grafting (CABG).
- To identify critical periods and mechanisms contributing to embolic events during cardiac surgery.
- To explore strategies for mitigating neurologic injury in cardiac surgical patients.
Main Methods:
- Comparison of neurologic outcome rates between intracardiac operations and CABG procedures.
- Utilizing transcranial Doppler (TCD) to measure embolic events during different phases of cardiac surgery.
- Reviewing evidence on risk factors and potential protective measures for CNS injury in cardiac surgery.
Main Results:
- Intracardiac surgery demonstrates a significantly higher incidence of overt CNS events compared to CABG.
- Transcranial Doppler monitoring reveals more embolic events during valve surgery, especially during cardiac ejection and post-bypass.
- Combined intracardiac and CABG procedures may present a particularly elevated risk for adverse neurologic outcomes.
Conclusions:
- Neurologic risk stratification and monitoring are crucial for patients undergoing cardiac surgery, especially intracardiac procedures.
- Intraoperative assessment tools like echocardiography and monitoring technologies (TCD, TEE) can identify at-risk patients and embolic events.
- Future advancements in cerebroprotective drugs offer potential for ameliorating neurologic injury in high-risk cardiac surgery patients.
Abstract:
Intracardiac operations such as valve replacements have typically carried a higher risk (4.2% to 13%) of overt central nervous system outcome, compared with coronary artery bypass grafting (CABG) procedures (0.6% to 5.2%). This is likely owing to the increased risk of macroembolization of air or particulate matter from the surgical field during intracardiac surgery. The periods of highest risk for emboli are during aortic cannulation and especially during release of aortic clamps and weaning from bypass. The number of embolic events measured with transcranial Doppler is significantly higher in patients undergoing valve surgery compared with coronary surgery, particularly during cardiac ejection and immediately after bypass. However, there is current evidence that neurologic risk is increasing in patients undergoing CABG owing to the tendency to operate on older patients with more severe aortic atherosclerosis and cerebrovascular disease. Patients having an intracardiac procedure combined with a CABG procedure may be at particularly high risk for adverse neurologic outcome. For all cardiac surgical patients, there is some cause for optimism in that risk may be minimized by improved assessment (e.g., intraoperative transesophageal or epiaortic echocardiographic scanning of the ascending aorta to identify patients at risk) and monitoring (e.g., detection of embolic phenomena, using transesophageal echocardiography or transcranial Doppler technology). Furthermore, in the future, development and testing of more ideal cerebroprotective drugs may allow amelioration of neurologic injury, either by pretreating all patients at risk, or possibly even by delaying treatment until after the suspected occurrence of an insult.